Novartis division Sandoz recalls one lot of blood pressure drug

Novartis said on Thursday its Sandoz division was recalling one lot of losartan tablets after finding traces of a probable carcinogen in the blood pressure drug.

Leave a Reply

Your email address will not be published. Required fields are marked *